Brandy Webb, N.D., Scientific Affairs manager at Probi, explores how GLP-1 therapies are reshaping nutrition science, product innovation, and metabolic health strategies. Seeing the microbiome as a metabolic infrastructure for GLP-1 signaling, she reveals actionable science that brands should be prioritizing now. Webb also touches on companion solutions backed by clinical evidence and how companies might navigate regulatory scrutiny tightening around peptides and grey-market products.
Upcoming webinars

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot
Register now

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa
Register now

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement















